Funding Mechanisms

The European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) share responsibility for the operation and the implementation of the Innovative Medicine Initiative (IMI). The legal entity to do this is the, so-called, IMI Joint Undertaking (IMI-JU) with its Governing Board, its Scientific Committee and its Executive Director (and offices), the latter issuing the calls for research activities and signing the Grant Agreement with the coordinating institution. 
Whereas academic participants and SMEs in an IMI project are funded by the 7th Research Framework Programme, the industrial partners - that have to be EFPIA members - contribute their own funds, matching the amount of public spending at at least a 100%. 

For more information on this new funding mechanisms and the calls please consult the IMI Web Site: imi-europe.org